Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOX-H94 in ESA-hyporesponsive Anemia in Dialysis
NCT02079896Phase 2Completed
- Sponsor
- TME Pharma
- Start
- May 2014
- Primary completion
- Nov 2015
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 3
01
Overview
A Phase 2 trial of lexaptepid pegol in anemia, sponsored by TME Pharma. Started May 2014; status: completed.
02
Drugs
lexaptepid pegol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02079896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079896.